TrialThe Journal of infectious diseases2026

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults.

Patricia Winokur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.